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ABSTRACT
Introduction. Characterization of the polymorphonu-
clear neutrophils functional activity during the diabe-
tes is of outmost importance for the understanding 
of the immunological processes involved in disease 
pathogenesis. The search for effective drugs that would 
suppress and/or modulate the immune response, pref-
erably without negative effects, is a promising area of 
modern research. Smallanthus sonchifolius Poepp. et 
Endl., which has long been used in folk medicine to 
treat diabetes, was proposed as a potential treatment 
for immune disorders. The study aimed to search for 
the effective drug which would be able to regulate 
neutrophils functional activity in experimentally in-
duced type 1 diabetes mellitus.
Material and methods. The experiments were con-
ducted on male Wistar rats. Diabetes was induced by 
intraabdominal injection of streptozotocin. For the 
evaluation of phagocytic activity and the content of 
cationic proteins and myeloperoxidase in neutrophils 
cytochemical studies were performed.
Results. Diabetes development was accompanied by 
reduced phagocytic activity of granulocytes and in-
creased activity of myeloperoxidase. All used extracts 
intensified phagocytic activity of neutrophil in diabe-
tes, with the yacon root tubers extract demonstrating 
the strongest effect, which was reflected by rapid 
degradation of particles engulfed by phagocytes.
Conclusions. It was established that yacon extracts 
inhibit myeloperoxidase activity in diabetes. Therefore 
all investigated extracts have a pronounced immuno-
corrective effect and can become the basis for creating 
a new generation of antidiabetic drugs. (Clin Diabetol 
2019; 8, 5: 248–253)
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Introduction
Polymorphonuclear neutrophil (PMN) is directly 
involved in pathogenesis of diabetes-associated com-
plications. Neutrophils are characterized by decreased 
phagocytic and bactericidal activities, which lead to an 
increased susceptibility to infections in patients with 
diabetes mellitus type 1 (DM) [1]. Among these anti-
microbial agents, myeloperoxidase (MPO) is the most 
abundant and constitutes 5% dry weight of neutrophils 
and 25% of azurophilic granular proteins [2]. Accept 
MPO, several other proteins or enzymes are present in 
neutrophils which also show antimicrobial properties: 
defensins (major antimicrobial cationic proteins), serine 
proteases, NADPH oxidase, etc. [3]. Yacon (Smallanthus 
sonchifolius Poepp. et Endl.) has long been used in folk 
medicine to treat diabetes. Active components from this 
plant are able to stimulate immune defense by promot-
ing antioxidant, antimicrobial, and anticancer effects 
[4]. This study aimed to search for the most effective 
yacon extract that would be able to regulate neutrophils 
functional activity under the experimental DM.
Material and methods
Preparation of water extracts of yacon
Preparation of water extracts of yacon was per-
formed according to Nagalievska et al. [5]. For the re-
search water solutions of evaporated extracts were used.
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Induction of diabetes
Following an overnight starvation, diabetes was 
induced by intraabdominal injection of streptozotocin 
(STZ, Sigma, USA) (freshly dissolved in 10 mM citrate 
buffer [pH 5.5]) at a dose of 0.055 g/kg body weight.
Experimental animals
Experiments were conducted using male Wistar 
rats weighing 150 to 220 g. The rats were kept in the 
animal house and fed with a standard laboratory diet 
and water ad libitum. Study was carried out according 
to the “General ethical principles of experiments on 
animals” (Kyiv, 2001) and the European Convention 
(Strasbourg, 1986). Animals were randomly divided into 
following groups (n = 5–8/group): control animals (C); 
control animals that were treated with extract of yacon 
leaves (C + YL); control animals that were treated with 
extract of yacon root tubers (C + YR); animals with DM 
(D); animals with DM that were treated with extract 
of yacon leaves (D + YL); animals with DM that were 
treated with extract of yacon root tubers (D + YR). In 
the D + YL and D + YR, groups the studied extracts 
started to be administered on the 14th day after induc-
tion of diabetes. Groups C + YL, D + YL, C + YR and 
D + YR were treated by extracts at dose 70 mg/kg per 
day orally through a tube with preservation of precise 
dosage for 2 weeks.
Collection of blood and leukocytes separation 
At the end of experimental period, the rats were 
starved for 15 h and then anesthetized using deep 
ether anesthesia method. Whole blood was collected 
and immediately transferred to heparinized tubes. 
Leukocytes were separated on gradient of Histopaque® 
1083 (density of 1.083 g/mL).
Cytochemical studies
Phagocytic Activity Assay was conducted according 
to Levinsky et. al [6]. Based on obtained results next 
phagocytosis indexes were calculated: PI — phagocytic 
index — percentage of cells started the phagocytosis, of 
the total number of cells (PI30 and PI120 after 30 min and 
120 min of incubation, respectively); PN — phagocytic 
number — average number of yeasts cells that were 
inside phagocytes (PN30 and PN120 respectively after 
30 min and 120 min of incubation); IPC — index of 
phagocytosis completeness — division quotient of PN30 
on PN120. Determination of cationic proteins content 
was made according to Shubych [7]. Determination of 
MPO level was performed by Graham-Knol method [8].
Evaluation of cytochemical studies
Evaluation of cytochemical studies were performed 
by semiquantitative method using Astraldi principle 
that is based on the differentiation of a specific color 
varying intensity (0, +, ++, +++). The results were 
expressed as the average cytochemical coefficient (ACC) 
— that was calculated using the formula:
ACC = A × 0 + B × 1 + C × 2 + D × 3n
where a number of cells with A — negative reaction, 
B — poorly positive reaction, C — moderately positive 
reaction, D — sharply positive reaction, n — a number 
of counted cells.
Statistical analysis
Quantitative data obtained from the study was 
performed by arithmetic mean — M, the standard 
deviation of the arithmetic mean — m. Reliability of 
the difference between statistical characteristics of 
two alternative data sets was performed by one-way 
analysis of variance. The difference was considered 
significant if P < 0.05.
Results
In the case of DM we have established the decrease 
in PI30 by 16.5% and PN30 by 19.3% compared to control. 
A slightly different picture was observed in the case of 
a longer incubation of neutrophils with yeast cells, in 
particular it was established the increase in PI120 at 28.8%, 
compared with the control. In animals with DM the in-
crease in average number of yeasts cells inside phagocytes 
was observed (Table 1). The decrease in IPC in DM by 
19.7% was shown compared to control value (Figure 1).
YL extract administration to animals with DM re-
sulted in 2.1-fold increase in PI30 and PI120 growth both 
in control animals and in animals with DM, respectively 
at 97.8% and at 75.1% compared to control. Adminis-
tration of YL extract to animals with DM leads to growth 
of PN30 (39.4%) and PN120 (8.2%) compared with 
diabetes. A similar growth of PN120 (20.9%) has been 
demonstrated when the extract was administrated 
to healthy animals (Table 1). We have established the 
increase in IPC after YL extract treatment compared to 
diabetic animals (Figure 1).
Using YR extract in the control animals cause 20.3% 
reduction of PI30, with subsequent growth of neutro-
phils that entered the phagocytosis at 120 min (Table 1).
In DM animals, the administration of YR extract 
caused the PI30 increase at 50.0%, compared with 
untreated DM animals. In the later stages of the phago-
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cytosis process (120 minute), the amount of consumed 
yeast cells were reduced almost to control level (Table 1). 
Thus, the usage of YR extract causes the growth of IPC 
to 28.5%, comparing to DM (Figure 1).
In animals with experimentally induced diabetes 
MPO ACC increased by 16.4%, compared to control ani-
mals. The use of YL and YR extracts caused no significant 
change in myeloperoxidase ACC in control animals. In 
DM reduction of ACC was established when using YL 
extract (15.3%) and when YR extract (11.0%) (Figure 2).
Discussion
The assessment of changes in phagocytic and bacte-
ricidal activity of PMN in diabetes and impact of agents 
with pronounced hypoglycemic effect on neutrophils 
functional activity is believed to be a promising research 
area. To test the phagocytic activity, rats’ neutrophils 
were allowed to phagocytize unopsonized yeast cells. 
Changes in phagocytosis activity indexes (Table 1, Fig-
ure 1) indicate that neutrophils require more time for 
an adequate response to foreign cells and particles [5].
Considering that neutrophils generate low 
amounts of ATP in their mitochondria and thus rely 
primarily on glycolytic metabolism, altered glucose 
levels in diabetes impact on neutrophil function [9].
Abnormal leukocyte function in DM might be 
caused by the formation of an advanced glycation 
end products (AGEs). AGEs may cause aberrant signal 
processing with some serious consequences in terms 
of stimulus-response coupling, in particular leads to 
transient actin polymerization, which is required for 
chemotactic, phagocytic, and secretory responses. 
Table 1. Neutrophils phagocytic activity indexes under administration of yacon extracts
(%) Number of yeast cells
PI30 PI120 PN30 PN120
C 13.17 ± 0.73 14.75 ± 0.88 1.76 ± 0.03 1.53 ± 0.09
C + YL 12.83 ± 0.44 29.17 ± 4.78* 1.62 ±0.03 1.85 ± 0.08*
C + YR 10.50 ± 0.29* 17.83 ± 1.42 1.71 ± 0.06 1.77 ± 0.07
D 11.00 ± 3.5 19.00 ± 0.50* 1.42 ± 0.08* 1.84 ± 0.08*
D + YL 23.50 ± 1.04*
# 25.83 ± 1.17*# 1.98 ± 0.04*# 1.99 ± 0.04*
D + YR 16.50 ± 1.19*
# 20.50 ± 2.46* 1.52 ± 0.04* 1.55 ± 0.16
*P < 0.05 compared with controls; #P < 0.05 compared with diabetic rats; PI30 — percentage of cells (phagocytic index) started the phagocytosis, of the 
total number of cells after 30 min of incubation; PI120 — percentage of cells started the phagocytosis, of the total number of cells after 120 min of incu-
bation; PN30 — average phagocytic number of yeasts cells that were inside phagocytes after 30 min of incubation; PN120 — average phagocytic number 
of yeasts cells that were inside phagocytes after 120 min of incubation; C — control animals; C + YL — control animals that were treated with extract of 
yacon leaves; C + YR — control animals that were treated with extract of yacon root tubers; D — animals with diabetes mellitus (DM); D + YL — animals 
with DM that were treated with extract of yacon leaves; D + YR — animals with DM that were treated with extract of yacon root tubers
Figure 1. Changes in index of phagocytosis completeness under yacon extracts administration. *P < 0.05 compared with con-
trols; #P < 0.05 compared with diabetic rats; C — control animals; C + YL — control animals that were treated with extract of 
yacon leaves; C + YR — control animals that were treated with extract of yacon root tubers; D — animals with diabetes mellitus 
(DM); D + YL — animals with DM that were treated with extract of yacon leaves; D + YR — animals with DM that were treated 
with extract of yacon root tubers
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The increased number of ingested yeast cells by neutro-
phils can also be associated with increased concentra-
tions of AGEs. Products of nonenzymatic glycosylation 
cause the increase in the number of ingested bacteria 
per cell [10].
Intensification of phagocytosis process under YL 
extract administration may be due to its pronounced 
hypoglycemic effect. This sugar lowering effect was 
shown in our previous research. Yacon leaves extracts 
in the condition of diabetes cause a decrease in glu-
cose concentration by 13.4%, while the root tubers 
extract caused a decrease in the content of the stud-
ied indicator by 49.9% [11]. Established effect may 
be due to the presence in yacon leaves sesquiterpene 
lactones, quercetin and other phenolic compounds, 
which have been shown to exhibit anti-inflammatory 
activity [12–14].
Demonstrated effect of YR extract (Table 1, Figure 1) 
can be caused by high content in their composition of 
inulin type b (2 Æ 1) fructooligosaccharides (FOS) [13]. 
Short-term supplementation of FOS cause the increase 
in white blood cells phagocytic activity through binding 
to carbohydrate receptors [4, 15].
The phagocytic event stimulates the release of 
agents into the phagolysosome that will kill and 
digest the ingested microorganism. The non-oxygen-
dependent mechanisms include the action of the 
enzymes contained in granules, such as antibacterial 
cationic proteins, lysozyme, various proteases, and 
direct effects of lactoferrin. The oxygen-dependent 
mechanisms are again of two types: MPO-dependent 
and MPO-independent. As a part of oxygen-dependent 
mechanisms of microorganism killing, we investigate 
the amount of MPO in PMN. Activated neutrophils 
release MPO from azurophilic granules at the sites of 
inflammation. MPO is able to interact with diverse ionic, 
atomic, and molecular entities via the interface with 
H2O2, including HOCl
–, hydroxyl radicals, singlet oxygen, 
ozone, chloramines, and aldehydes. These species are 
potent oxidants, which under normal and controlled 
circumstances are toxic to several microorganisms and 
play an important role in the immune system [2].
The overproduction of MPO by neutrophils from 
animals with DM (Figure 2) can causes oxidative damage 
of proteins and DNA in host cells. Thus, the enhanced 
level of MPO is one of the best inflammatory and oxi-
dative stress markers of diabetes [2]. This enzyme can 
bind other cell surfaces like epithelial cells, fibroblasts, 
endothelial cells, macrophages, platelets, neutrophils. 
The binding of enzyme to these cell surfaces alters 
some functional properties: interaction with neutrophil 
integrins causes enhanced tyrosine phosphorylation of 
some proteins. This activates protein tyrosine kinase, 
which results in degranulation and leads to respira-
tory burst. The binding of MPO to platelets causes the 
reorganization of platelet cytoskeleton, and thus alters 
the aggregation properties [2, 16].
Reduction of MPO ACC when using YL leave 
extracts (Figure 2) can be caused by the presence in 
its composition phenolic antioxidants (ferulic acid, 
chlorogenic acid, gallic acid, caffeic acid, rosmarinic 
acid and quercetin) and flavonoids (apigenin and lu-
teolin), which can inhibit MPO [13, 17, 18]. Somewhat 
less pronounced effect on MPO activity possessed YR 
extract that may be due to lower content or lack of 
components that are capable to inhibit the activity of 
Figure 2. Changes in average cytochemical coefficient (ACC) of myeloperoxidase and cationic proteins under yacon extracts ad-
ministration. *P < 0.05 compared with controls; #P < 0.05 compared with diabetic rats; C — control animals; C + YL — control 
animals that were treated with extract of yacon leaves; C + YR — control animals that were treated with extract of yacon root 
tubers; D — animals with diabetes mellitus (DM); D + YL — animals with DM that were treated with extract of yacon leaves; 
D + YR — animals with DM that were treated with extract of yacon root tubers
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enzyme. FOS, which are the major biologically active 
substances in yacon root tubers also tended to reduce 
MPO activity [4].
In order to obtain additional data on the violation 
of bactericidal properties of neutrophils in diabetes, 
we investigate the amount of antibacterial cationic 
proteins as part of non-oxygen-dependent microbe 
killing mechanisms [19]. In our studies, we did not find 
significant change in cationic proteins ACC (Figure 2).
Conclusions
DM development was accompanied by reduced 
phagocytic activity of granulocytes with activation 
of oxygen-dependent mechanisms of microorganism 
killing. All used extracts intensified phagocytic activity 
of neutrophil in diabetes, with the yacon root tubers 
extract demonstrating the strongest effect, which was 
reflected by rapid degradation of particles engulfed by 
phagocytes. Yacon extracts possess inhibiting effect on 
myeloperoxidase activity in diabetes (Figure 3).
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